Invivyd, Inc. (IVVD)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
IVVD Insider Trading Activity
IVVD Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $1,023,529 | 16 | 100 |
Related Transactions
| MCGUIRE TERRANCE | director | 0 | $0 | 16 | $1.02M | $-1.02M |
About Invivyd, Inc.
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research …
Insider Activity of Invivyd, Inc.
Over the last 12 months, insiders at Invivyd, Inc. have bought $0 and sold $1.02M worth of Invivyd, Inc. stock.
On average, over the past 5 years, insiders at Invivyd, Inc. have bought $0 and sold $10.39M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
List of Insider Buy and Sell Transactions, Invivyd, Inc.
| 2024-12-31 | Sale | MCGUIRE TERRANCE | director | 103,474 0.0894% | $0.45 | $46,098 | +106.48% | |
| 2024-12-30 | Sale | MCGUIRE TERRANCE | director | 86,545 0.0685% | $0.48 | $41,784 | +90.73% | |
| 2024-12-27 | Sale | MCGUIRE TERRANCE | director | 83,744 0.0705% | $0.52 | $43,647 | +65.86% | |
| 2024-12-26 | Sale | MCGUIRE TERRANCE | director | 83,817 0.0712% | $0.54 | $45,563 | +59.16% | |
| 2024-12-24 | Sale | MCGUIRE TERRANCE | director | 68,161 0.0566% | $0.51 | $34,503 | +65.23% | |
| 2024-12-23 | Sale | MCGUIRE TERRANCE | director | 75,776 0.0605% | $0.45 | $34,076 | +75.60% | |
| 2024-12-20 | Sale | MCGUIRE TERRANCE | director | 119,805 0.1005% | $0.42 | $50,725 | +82.92% | |
| 2024-12-19 | Sale | MCGUIRE TERRANCE | director | 152,067 0.1277% | $0.43 | $65,951 | +88.12% | |
| 2024-12-18 | Sale | MCGUIRE TERRANCE | director | 74,764 0.066% | $0.47 | $35,087 | +80.99% | |
| 2024-12-17 | Sale | MCGUIRE TERRANCE | director | 97,410 0.0782% | $0.48 | $46,757 | +38.95% | |
| 2024-12-16 | Sale | MCGUIRE TERRANCE | director | 65,359 0.0553% | $0.47 | $30,510 | +23.64% | |
| 2024-12-12 | Sale | MCGUIRE TERRANCE | director | 125,000 0.1041% | $0.58 | $72,875 | -5.67% | |
| 2024-12-11 | Sale | MCGUIRE TERRANCE | director | 160,400 0.135% | $0.59 | $94,812 | -5.48% | |
| 2024-12-10 | Sale | MCGUIRE TERRANCE | director | 175,000 0.1459% | $0.59 | $103,005 | -7.17% | |
| 2024-12-09 | Sale | MCGUIRE TERRANCE | director | 150,000 0.1261% | $0.61 | $91,560 | -3.65% | |
| 2024-05-29 | Sale | MCGUIRE TERRANCE | director | 112,381 0.2233% | $1.66 | $186,575 | -41.00% | |
| 2024-01-19 | Sale | Adimab, LLC | 10 percent owner | 5M 23.6347% | $3.95 | $19.75M | -74.47% |
IVVD Institutional Investors: Active Positions
| Increased Positions | 36 | +42.35% | 14M | +19.15% |
| Decreased Positions | 32 | -37.65% | 8M | -11.87% |
| New Positions | 13 | New | 12M | New |
| Sold Out Positions | 13 | Sold Out | 5M | Sold Out |
| Total Postitions | 89 | +4.71% | 77M | +7.27% |
IVVD Ownership Change vs Market
Institutional Investor Ownership
| Maverick Capital Ltd | $9,471.00 | 9.81% | 11.77M | 0 | 0% | 2024-12-31 |
| Mithril Ii Gp Lp | $9,049.00 | 9.37% | 11.24M | +11M | New | 2024-12-31 |
| Deep Track Capital, Lp | $8,605.00 | 8.91% | 10.69M | -264,334 | -2.41% | 2024-12-31 |
| M28 Capital Management Lp | $7,445.00 | 7.71% | 9.25M | 0 | 0% | 2024-12-31 |
| Fmr Llc | $4,649.00 | 4.81% | 5.78M | -2M | -21.11% | 2024-12-31 |
| Blackrock, Inc. | $3,819.00 | 3.95% | 4.74M | +71,833 | +1.54% | 2024-12-31 |
| Vanguard Group Inc | $3,494.00 | 3.62% | 4.34M | -25,906 | -0.59% | 2024-12-31 |
| Redmile Group, Llc | $2,425.00 | 2.51% | 3.01M | -53,460 | -1.74% | 2024-12-31 |
| 683 Capital Management, Llc | $2,415.00 | 2.5% | 3M | 0 | 0% | 2024-12-31 |
| Bain Capital Life Sciences Investors, Llc | $1,449.00 | 1.5% | 1.8M | 0 | 0% | 2024-12-31 |